NASDAQ · Shell Companies · USD

JATT II Acquisition Corp. (JATT) Stock Analysis

JATT II Acquisition Corp. (JATT) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

JATT

$12.20

−$0.05 (−0.41%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare JATT with… →

JATT Key Statistics

As of Sep 4, 2026

Trading

Open: $12.25
Previous Close: $12.25
Day's Range: 12.00–12.30
52-Week Range: 9.99–23.76
Volume: 15.30K

Valuation

Market Cap: $95.16M

Financials (FY)

Profit margin: 0.00%
Shares Outstanding: 7.80M

Dividend and dates

Avg Volume: 21.02K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

JATT Valuation vs Shell Companies Median

Median of 587 stocks

Metric	JATT	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values JATT II Acquisition Corp. (JATT) at $95.16M. It is classified in the Shell Companies industry, within the Financial Services sector.

Over the past 52 weeks the price has ranged from $9.99 to $23.76. The most recent close on file for JATT is $12.20, dated September 4, 2026. That is −$0.05 (−0.41%) against the previous close. The latest close sits 22.12% above that 52-week low.

Financial Health

The reported profit margin is 0%.

Growth & Income

No dividend is on file for JATT.

2026 is still running; the price is +16.19% year to date.

Peer Comparison

JATT II Acquisition Corp. (JATT) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
JATT II Acquisition Corp.	JATT	$95.16M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. JATT II Acquisition Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About JATT II Acquisition Corp.

JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey.

Visit website →